In combination, these results indicate that ISG12 promotes the interaction of ERα with the nuclear exportin CRM1/XPO1 and suggest that the ISG12-dependent down-regulation of ERα transactivation may be mediated by its export from the nucleus in breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.